Literature DB >> 23937438

Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.

Niloofar N Nik1, Russell Vang, Ie-Ming Shih, Robert J Kurman.   

Abstract

A new paradigm for the pathogenesis of female pelvic cancer helps explain persistent problems in describing the development and diverse morphology of these neoplasms. This paradigm incorporates recent advances in the molecular pathogenesis of epithelial ovarian cancer (EOC) with new insights into the origin of these tumors. Correlated clinicopathologic and molecular genetic studies gave rise to a dualistic model that divides the various histologic types of EOCs into two broad categories designated type I and type II. Because serous carcinomas are the most common EOC and account for the vast majority of deaths, they form the subject of this review. Recent studies indicate that the precursor of ovarian high-grade serous carcinoma appears to develop from an occult intraepithelial carcinoma in the fimbria of the fallopian tube and involves the ovary secondarily. Another possible mechanism is implantation of normal fimbrial epithelium on the denuded ovarian surface at the site of rupture when ovulation occurs, causing the development of cortical inclusion cysts. The dualistic model serves as a framework for the study of ovarian cancer and can help investigators organize this complex group of neoplasms. It also facilitates the development of novel approaches to prevention, screening, and treatment of this devastating disease.

Entities:  

Mesh:

Year:  2013        PMID: 23937438     DOI: 10.1146/annurev-pathol-020712-163949

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  66 in total

1.  Follicle Depletion Provides a Permissive Environment for Ovarian Carcinogenesis.

Authors:  Ying Wang; Kathy Qi Cai; Elizabeth R Smith; Toni M Yeasky; Robert Moore; Parvin Ganjei-Azar; Andres J Klein-Szanto; Andrew K Godwin; Thomas C Hamilton; Xiang-Xi Xu
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

2.  Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Authors:  Rachel A Davidowitz; Laura M Selfors; Marcin P Iwanicki; Kevin M Elias; Alison Karst; Huiying Piao; Tan A Ince; Michael G Drage; Judy Dering; Gottfried E Konecny; Ursula Matulonis; Gordon B Mills; Dennis J Slamon; Ronny Drapkin; Joan S Brugge
Journal:  J Clin Invest       Date:  2014-04-24       Impact factor: 14.808

Review 3.  Emerging diagnostic, prognostic and therapeutic biomarkers for ovarian cancer.

Authors:  Khalid El Bairi; Abdul Hafeez Kandhro; Adel Gouri; Wafaa Mahfoud; Noureddine Louanjli; Brahim Saadani; Said Afqir; Mariam Amrani
Journal:  Cell Oncol (Dordr)       Date:  2016-12-15       Impact factor: 6.730

4.  The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice.

Authors:  Jaeyeon Kim; Donna M Coffey; Lang Ma; Martin M Matzuk
Journal:  Endocrinology       Date:  2015-03-27       Impact factor: 4.736

5.  TET1 reprograms the epithelial ovarian cancer epigenome and reveals casein kinase 2α as a therapeutic target.

Authors:  Lin-Yu Chen; Rui-Lan Huang; Michael Wy Chan; Pearlly S Yan; Tien-Shuo Huang; Ren-Chin Wu; Yohan Suryo Rahmanto; Po-Hsuan Su; Yu-Chun Weng; Jian-Liang Chou; Tai-Kuang Chao; Yu-Chi Wang; Ie-Ming Shih; Hung-Cheng Lai
Journal:  J Pathol       Date:  2019-04-23       Impact factor: 7.996

Review 6.  Salpingectomy as a means to reduce ovarian cancer risk.

Authors:  Mary B Daly; Charles W Dresher; Melinda S Yates; Joanne M Jeter; Beth Y Karlan; David S Alberts; Karen H Lu
Journal:  Cancer Prev Res (Phila)       Date:  2015-01-13

7.  N-glycan MALDI Imaging Mass Spectrometry on Formalin-Fixed Paraffin-Embedded Tissue Enables the Delineation of Ovarian Cancer Tissues.

Authors:  Arun V Everest-Dass; Matthew T Briggs; Gurjeet Kaur; Martin K Oehler; Peter Hoffmann; Nicolle H Packer
Journal:  Mol Cell Proteomics       Date:  2016-07-13       Impact factor: 5.911

8.  Tubal origin of ovarian low-grade serous carcinoma.

Authors:  Chenglu Chen; Jie Li; Guang Yao; Setsuko K Chambers; Wenxin Zheng
Journal:  Am J Clin Exp Obstet Gynecol       Date:  2013-12-15

9.  High expression of S100P is associated with unfavorable prognosis and tumor progression in patients with epithelial ovarian cancer.

Authors:  Xiangyu Wang; Tian Tian; Xukun Li; Meng Zhao; Yanhui Lou; Jingfeng Qian; Zhihua Liu; Hongyan Chen; Zhumei Cui
Journal:  Am J Cancer Res       Date:  2015-07-15       Impact factor: 6.166

10.  Cyclin E1 deregulation occurs early in secretory cell transformation to promote formation of fallopian tube-derived high-grade serous ovarian cancers.

Authors:  Alison M Karst; Paul M Jones; Natalie Vena; Azra H Ligon; Joyce F Liu; Michelle S Hirsch; Dariush Etemadmoghadam; David D L Bowtell; Ronny Drapkin
Journal:  Cancer Res       Date:  2013-12-23       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.